Keith Goldan Insider Profile

4 Followers
Keith Goldan, SVP and CFO at Fibrocell Science, holds 52.62K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 141.73K shares in Optinose (Ticker: OPTN), holds 2.00K shares in Fibrocell Science (Ticker: FCSC). Most recently, Keith Goldan Bought ― shares of Syndax Pharmaceuticals on Jun 17, 2024 for an estimated value of 25.02K.
tipranks
Keith Goldan

Keith Goldan
Fibrocell Science (FCSC)
SVP and CFO

Ranked #72,665 out of 99,335 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

-21.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
91.33%
8.67%
A breakdown of Keith Goldan's holdings

Insider Roles

Syndax Pharmaceuticals
(SNDX)
CFO
Optinose
(OPTN)
CFO
Roles that Keith Goldan holds in companies

Most Profitable Insider Trade

Stock:
Syndax Pharmaceuticals
(SNDX)
Rating:Informative Buy
Date:Jun 17, 2024 - Today
Return:+9.70%
The most profitable trade made by Keith Goldan

Keith Goldan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FCSC
Fibrocell Science
Aug 11, 2015
Informative Buy
12.66K
$6.00K
Optinose
Mar 17, 2022
CFO
Uninformative Sell
9.74K
$108.85K
Syndax Pharmaceuticals
Jun 17, 2024
CFO
Informative Buy
25.02K
$1.15M
~PATH
Nupathe Inc
Feb 25, 2014
Uninformative Sell
1.13M
List of latest transactions for each holding click on a transaction to see Keith Goldan's performance on stock

Keith Goldan insider profile FAQ

What is the percentage of profitable transactions made by Keith Goldan?
The percentage of profitable transactions made by Keith Goldan is 67%.
    What is the average return per transaction made by Keith Goldan?
    The average return per transaction made by Keith Goldan is -21.60%.
      What stocks does Keith Goldan hold?
      Keith Goldan holds: FCSC, OPTN, SNDX, ~PATH stocks.
        What was Keith Goldan’s latest transaction?
        Keith Goldan latest transaction was an Informative Buy of $25.02K.
          What was Keith Goldan's most profitable transaction?
          Keith Goldan’s most profitable transaction was an Informative Buy of SNDX stock on June 17, 2024. The return on the trade was 9.70%.
            What is Keith Goldan's role in Fibrocell Science?
            Keith Goldan's role in Fibrocell Science is SVP and CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.